Oxymist Paed 0.025% Nasal Spray
By Oxymist
10ml Nasal Spray in a Bottle

Composition
Oxymetazoline(0.025% w/v)

Manufacturer - Moon Healthcare Pvt Ltd
121 Vel Amrutha Towers, #15 Nallanna Mudali Street, Royapettah, Chennai - 600014

Expires on or after
September, 2025

liver
Currently, there is no known interaction between Oxymist Paed 0.025% Nasal Spray and the liver. This means that there are no documented risks or concerns specifically related to the liver when using this nasal spray. However, as with any medication, it is always advisable to consult with your healthcare provider or doctor before starting to use Oxymist Paed 0.025% Nasal Spray, especially if you have any existing liver conditions or concerns. Your doctor will be able to provide you with personalized guidance and ensure that the nasal spray is safe for you to use.

kidney
Consult with your doctor for proper guidance before using Oxymist Paed 0.025% Nasal Spray.

alcohol
Consult your doctor when consuming alcohol with Oxymist Paed 0.025% Nasal Spray.

driving
No interaction has been found or established between Oxymist Paed 0.025% Nasal Spray and driving.

pregnancy
Oxymist Paed 0.025% Nasal Spray may not be safe to use during pregnancy. Animal studies have indicated potential harm to the baby. Consult your doctor for advice before using.

breastfeeding
Oxymist Paed 0.025% Nasal Spray is likely safe while breastfeeding. Minimal data shows minimal risk to the baby. To minimize transfer to breastmilk, remove excess spray with a tissue.
Habit Forming | No |
Chemical Class | Imidazole Derivative |
Therapeutic Class | - |
Action Class | Sympthatomimmetics- alpha 1 (Nasal) |
₹58
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025